Month: August 2022

HOUSTON, Aug. 24, 2022 (GLOBE NEWSWIRE) — Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company, today announced that it has been accepted to present a proffered talk at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference (CICON) being held in New York, NY from September 28 – October 1, 2022. Details of the presentation are as follows: Title: Objective clinical response by KRAS mutation-specific TCR-T cell therapy in previously treated advanced Non-small cell lung cancerPresenter: Marcelo V. Negrao, MD, Department of Thoracic-Head & Neck Med Onc, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center Date and Time: Friday, September 30, 2022, 8:30am ETSession Title: Session 6: Cellular Therapies: Engineering...

CINCINNATI, Aug. 24, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that scientists from its research partner, The University of Oxford, will present at The Universal Influenza Vaccines 2022 Conference in Oxford, United Kingdom on Monday, September 5th, 2022. Sunetra Gupta, Ph.D., Professor of Theoretical Epidemiology at The University of Oxford and current member of the BWV Scientific Advisory Board, will present BWV’s approach to a universal influenza vaccine, BWV-101, containing epitopes of limited variability identified for influenza H1, H3, and influenza B. The Company is also developing a standalone H1 pre-pandemic vaccine containing epitopes...

Nokia CorporationStock Exchange Release24 August 2022 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 24.08.2022 Espoo, Finland – On 24 August 2022 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 200,935 4.95CEUX 24,163 4.95AQEU 11,869 4.95TQEX 8,033 4.95Total 245,000 4.95* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU)...

Oxford, MS Pokemoto Hawaiian Poke Bowl RestaurantPokemoto Opens in Oxford, Home of University of Mississippi Burleson, Texas, Aug. 24, 2022 (GLOBE NEWSWIRE) — Pokemoto, Muscle Maker, Inc.’s (Nasdaq: GRIL) expanding Hawaiian poke bowl restaurant concept, today announced the grand opening of its first Mississippi franchise location in Oxford, Mississippi. The opening marks the first of three previously inked franchise deals in the Mississippi market. Being near “Ole Miss” provides exposure to Pokemoto’s core targeted audience – Millennials and Gen Zs. The location features Pokemoto’s brand new interior graphic design package, signage and menu items. “We are very excited to be opening our first Pokemoto location in Mississippi, especially in Oxford – the home of the University of Mississippi. This opening marks one of our...

VANCOUVER, British Columbia, Aug. 24, 2022 (GLOBE NEWSWIRE) — Kintavar Exploration Inc. (TSXV:KTR) completed the summer drilling program on the MLI corridor and released additional results from its surface exploration program on the Wabash project. Its 100% owned flagship project, the Mitchi–Wabash copper-silver district, is located 100 km north of the town of Mont-Laurier and 15 km East of the town of Parent in Quebec. A Media Snippet accompanying this announcement is available by selecting the image or link below:For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company. The video is available for viewing on “InvestmentPitch.com” and on “YouTube”. If these links are not enabled, please visit www.InvestmentPitch.com and enter “Kintavar” in the search...

Leuven, BELGIUM, Boston, MA, US – August 24, 2022 – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announced that it will participate in three upcoming conferences. 22ndEURETINA Congress – Hamburg, GermanyDate: Friday, September 2, 2022 | 12:15 p.m. CET   Title: “Results of Part A of KALAHARI, a Phase 2 Trial of THR-149, a plasma kallikrein (pKal) inhibitor, for the treatment of diabetic macular edema (DME)” presented by Timothy L. Jackson, MD. H.C. Wainwright & Co., 24thAnnual Global Investment Conference – New York, NY & Virtual Date: Monday, September 12, 2022 | 7:00 a.m. ET Tom Graney, CEO of Oxurion, will deliver a virtual presentation and is available for one-on-one meetings.   KBC...

PRESS RELEASE AB SCIENCE ANNOUNCES FILING OF MARKETING AUTHORIZATION APPLICATION FOR ALSITEK IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND ITS VALIDATION BY THE EUROPEAN MEDICINES AGENCY (EMA) Paris, 24 August 2022, 7pm CET AB Science SA (Euronext – FR0010557264 – AB) today announced that it has filed an application for conditional Marketing Authorization to the European Medicines Agency (EMA) for Alsitek (masitinib) in the treatment of amyotrophic lateral sclerosis (ALS). This application has now been validated by EMA and review by the Committee for Medicinal Products for Human Use (CHMP) has begun. The CHMP has a target of 210 active evaluation days to review the application. The application is based on results from the phase 2/3 AB10015 study and its long-term survival follow-up. Study AB10015 was a randomized,...

Industri Energi and Norsk Industri have today agreed on a solution to the labor dispute regarding the revision of the Electrochemical Agreement. The strike at Hydro Sunndal will be called off with immediate effect. Hydro Sunndal will resume normal operations from tomorrow and shipping of products to customers will resume. Potential delays to customers are expected to be minor. Investor contact: Line Haugetraa +47 41406376Line.Haugetraa@hydro.com Media contact: Halvor Molland +47 92979797Halvor.Molland@hydro.com